Anticipating and rebutting likely lines of attack is the best strategy, on both partisan and civic grounds.
Medicare
The Drug Price/Tax Break Quid Pro Quo
Democrats in high-tax states cut a deal on the Build Back Better Act.
World’s Biggest Half-Full, Half-Empty Glass
Today on TAP: Biden’s bill is historically great and bitterly disappointing.
What’s in the Build Back Better Framework
It has its selling points. But it doesn’t appear to meet the test of permanent, hassle-free, and meaningful.
The Drug Industry–Backed PAC Trying to Spike the Biden Agenda
Center Forward is funding practically all the corporate Democrats making trouble in Congress.
Lowering Drug Prices Is Personal for Millions of Americans
Lost in the technical debate over drug prices is a struggle to afford medications happening across the country.
Democrats Expand Obamacare While Abandoning It
While learning the lessons of the Affordable Care Act, Democrats are still building on top of it instead of seeking a better design.
Kathleen Rice’s Questionable Rationale for Voting Down Drug Pricing Reform
She says she voted against the measure because the reconciliation bill won’t become law.
How Kathleen Rice Is Threatening the Biden Agenda
Rice and two other House Democrats oppose aggressive drug price reform, which provides the budget savings available to fuel spending in the Build Back Better Act.
House, Senate Spar Over Reducing Drug Prices
There’s overwhelming support among Democrats for finally allowing Medicare to negotiate with drug companies. But the details matter.
